Arab Finance: Integrated Diagnostics Holdings (IDH) logged a 5.7% year-on-year (YoY) decrease in consolidated net profits attributable to the parent company in 2023, recording EGP 510.304 million, versus EGP 541.11 million, as per a statement.

However, revenues rose to EGP 4.123 billion last year from EGP 3.605 billion a year earlier.

Respecting standalone results, IDH incurred $77.33 million in net losses in 2023, against net profits of $71.635 million in 2022.

IDH is a consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan, and Nigeria.

The group’s core brands include Al Borg, Al Borg Scan, and Al Mokhtabar in Egypt, as well as Biolab in Jordan, Ultralab, and Al Mokhtabar Sudan both in Sudan, and Echo-Lab in Nigeria.

Egypt-Kuwait trade down 11.8% YoY in 2023 Updated 5/1/2024 2:54:00 PM

Egypt’s trade deficit falls 37.2% YoY in January Updated 4/4/2024 11:10:00 AM

Egypt’s GDP growth rate hits 2.3% in Q2 FY 2023/24 Updated 4/1/2024 10:22:00 AM

MTI’s consolidated profits jump 100.5% YoY in 2023 Updated 3/28/2024 10:28:00 AM

aiBANK’s profits rise 119% YoY in 2023 Updated 3/27/2024 1:10:00 PM